Half of VHL-Associated Kidney Tumors Respond to HIF2A Inhibitor
Even higher response rate seen among patients' pancreatic lesions
Source: medpagetoday.com
Page 4 - Eric Jonasch News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Eric Jonasch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Eric Jonasch Today - Breaking & Trending Today
FDA Approves Merck's Hypoxia-Inducible Factor-2 Alpha Inhibitor WELIREG for the Treatment of Patients With Certain Types of Von Hippel-Lindau Disease-Associated Tumors
WELIREG Approved for Adult Patients With VHL Disease Who Require Therapy for Associated Renal Cell Carcinoma, Central Nervous System Hemangioblastomas, or Pancreatic Neuroendocrine Tumors, Not Requiring Immediate Surgery WELIREG Expands Merck’s Oncology Portfolio as the First and Only Systemic Therapy Approved for These Patients With VHL Disease Merck known as MSD outside the United States and Canada, today ...
Source: investingnews.com
JNCCN Study: Important Potential Role for Routine Brain Imaging in Advanced Kidney Cancer
Share this article PLYMOUTH MEETING, Pa., April 13, 2021 /PRNewswire/ -- The April 2021 issue of JNCCN—Journal of the National Comprehensive Cancer Network publishes new research from Memorial Sloan Kettering Cancer Center (MSK) and Gustave Roussy Institute, which suggests that baseline brain imaging should be considered in most patients with metastatic kidney cancer. The researchers studied 1,689 patients with metastatic renal cell carcinoma (mRCC) who had been considered for clinical trial participation at either of the two institutions between 2001 and 2019 and had undergone brain imag...
Source: prnewswire.com
2021 Research Grant Recipients Announced by the VHL Alliance
2021 Research Grant Recipients Announced by the VHL Alliance Global Research Program Supports Curing Cancer through VHL News provided by Share this article Share this article BOSTON, Jan. 19, 2021 /PRNewswire/ -- The VHL Alliance (VHLA) today announced the 2021 recipients of the VHLA Competitive Research Grant Program. This year, three grantees were chosen. Scientists are increasingly aware that curing von Hippel-Lindau disease, a genetic form of cancer – is a key step to curing cancer, leading to a significant increase in the quality of research grant applicants in the program year afte...
Source: prnewswire.com